http://rdf.ncbi.nlm.nih.gov/pubchem/reference/3802269

Outgoing Links

Predicate Object
contentType Journal Article|Randomized Controlled Trial|Research Support, Non-U.S. Gov't
endingPage 39
issn 1464-2662
issueIdentifier 1
pageRange 31-39
publicationName HIV Medicine
startingPage 31
bibliographicCitation Cooper DA, Cordery DV, Reiss P, Henry K, Nelson M, O'Hearn M, Reynes J, Arastéh K, Chung J, Rowell L, Guimaraes D, Bertasso A; TORO 1 and TORO 2 Study Groups. The effects of enfuvirtide therapy on body composition and metabolic parameters over 48 weeks in the TORO body imaging substudy. HIV Med. 2011 Jan;12(1):31–9. doi: 10.1111/j.1468-1293.2010.00845.x. PMID: 20497250.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_08d3d7de8427ad5397e36385b08bd445
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ed7487eb1ed7df9d086ec4fb00d80634
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_00fca2d897388861b5d2601d2cde31d1
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_84a2e1389dc167060faa21d2229a859b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e5a16687b6a59b89e96e9f62b8905c11
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c0d5899359402fcec1a343890fa4c801
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_84a60b165cf8dc51141754fca17f706d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e4b4d231f384db2097ae1d796eca4e57
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3f7a939946ec562ab80eac26718d21bf
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d1f6c5c8ef320a1ad54bfa6d95579b82
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_528b9d564c4f59caa2b928de9c6e32f7
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c8581075981c0601a768b6e8805d030b
date 2010-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://doi.org/10.1111/j.1468-1293.2010.00845.x
https://pubmed.ncbi.nlm.nih.gov/20497250
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/26808
https://portal.issn.org/resource/ISSN/1464-2662
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title The effects of enfuvirtide therapy on body composition and metabolic parameters over 48 weeks in the TORO body imaging substudy*
discusses http://id.nlm.nih.gov/mesh/M0365995
http://id.nlm.nih.gov/mesh/M0016224
http://id.nlm.nih.gov/mesh/M0274523
http://id.nlm.nih.gov/mesh/M0024085
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D050171Q000139
http://id.nlm.nih.gov/mesh/D015658Q000188
http://id.nlm.nih.gov/mesh/D023581Q000009
http://id.nlm.nih.gov/mesh/D010446Q000009
http://id.nlm.nih.gov/mesh/D001823Q000187
http://id.nlm.nih.gov/mesh/D015700Q000009
hasSubjectTerm http://id.nlm.nih.gov/mesh/D000293
http://id.nlm.nih.gov/mesh/D039682Q000139
http://id.nlm.nih.gov/mesh/D015658Q000378
http://id.nlm.nih.gov/mesh/D008875
http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D000369
http://id.nlm.nih.gov/mesh/D000368
http://id.nlm.nih.gov/mesh/D050171Q000453
http://id.nlm.nih.gov/mesh/D055815
http://id.nlm.nih.gov/mesh/D023581Q000494
http://id.nlm.nih.gov/mesh/D014057
http://id.nlm.nih.gov/mesh/D023241Q000379
http://id.nlm.nih.gov/mesh/D023241Q000009
http://id.nlm.nih.gov/mesh/D000328
http://id.nlm.nih.gov/mesh/D015502
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D010446Q000494
http://id.nlm.nih.gov/mesh/D000077560
http://id.nlm.nih.gov/mesh/D055105Q000187
http://id.nlm.nih.gov/mesh/D001835Q000187
http://id.nlm.nih.gov/mesh/D049629
http://id.nlm.nih.gov/mesh/D015700Q000494
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16130199
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_cdf1e220d89c2dcd2e000c3d105bf93e
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5997
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5793
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5460048

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128121087
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135754805
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129621433
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129408911

Total number of triples: 71.